EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs

Johanna Seifert iD, Renate Grohmann, Sermin Toto iD, Matthias A Reinhard iD, Stefan Bleich, Andreas Erfurth iD, Cornelius Schüle, Susanne Stübner iD, Catherine Glocker iD

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04900-7 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Johanna Seifert und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany. seifert.joha…. Hauptthemen laut MEDLINE: Pharmacovigilance, Antidepressive Agents, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Hochschule Hannover (MHH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is more prevalent in women. Antidepressant drugs (ADDs) are often associated with an increased risk for adverse drug reactions (ADRs). Women generally appear to be at greater risk for ADRs. This observational study analyzed the incidence of ADD-related ADRs in relation to sex in 151,426 female and 92,162 male psychiatric inpatients using data from the German pharmacovigilance program “Arzneimittelsicherheit in der Psychiatrie” (AMSP) from 1993 to 2016. The type of ADR and the incidence of ADRs for different ADDs are examined. Among women and men, 0.85% and 0.67% suffered from ADD-induced ADRs (relative risk 1.25, 95% confidence interval 1.15–1.35), respectively. Women had a higher incidence of edema (f 0.055% vs m 0.009%; RR 6.31, CI 3.06–13.04), allergic cutaneous reactions (f 0.057% vs m 0.034%; RR 1.71, CI 1.13–2.57), and hyponatremia (f 0.067% vs m 0.024%; RR 2.82, CI 1.78–4.47). The incidence of sexual dysfunction was significantly higher in men (m 0.044% vs f 0.001%; RR 17.95, CI 4.39–73.48). Almost all ADD classes had a higher incidence of ADRs in women, including selective serotonin reuptake inhibitors (f 0.61% vs m 0.46%; RR 1.25, CI 1.04–1.50), noradrenergic and specific serotonergic antidepressants (f 0.71% vs m 0.48%; RR 1.46, CI 1.18–1.81), and tricyclic antidepressants (f 1.02% vs m 0.92%; RR 1.24, CI 1.03–1.49). These findings highlight the importance of considering sex-specific tolerability of ADDs. An understanding of these differences is a prerequisite for the individualization and optimization of patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceAntidepressive AgentsDrug-Related Side Effects and Adverse ReactionsHumansFemaleMaleAdultMiddle AgedSex FactorsIncidenceGermanyYoung AdultAdverse Drug Reaction Reporting SystemsAged

Stichwörter der Autor:innen

HyponatremiaMental healthSex factorsSexual dysfunctionWeight gain

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany. seifert.johanna@mh-hannover.de.
  • Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.
  • Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
  • Department of Psychiatry and Psychotherapeutic Medicine, Klinik Hietzing, Vienna, Austria.
  • Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
  • Department of Forensic Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, Rheinau, Switzerland.

ORCID-Profile: Johanna Seifert, Sermin Toto, Matthias A Reinhard, Andreas Erfurth, Susanne Stübner, Catherine Glocker

Förderung

  • Medizinische Hochschule Hannover (MHH)

Zitieren

APA

Seifert, J., Grohmann, R., Toto, S., Reinhard, M. A., Bleich, S., Erfurth, A., Schüle, C., Stübner, S., & Glocker, C. (2026). A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04900-7

Vancouver

Seifert J, Grohmann R, Toto S, Reinhard MA, Bleich S, Erfurth A, et al. A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04900-7

BibTeX
@article{Seifert2026,
  author = {Seifert, Johanna and Grohmann, Renate and Toto, Sermin and Reinhard, Matthias A and Bleich, Stefan and Erfurth, Andreas and Schüle, Cornelius and Stübner, Susanne and Glocker, Catherine},
  title = {A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04900-7}
}
Kostenlos starten →